In The Press

Arbitration Confirms NovelStem Joint Venture’s Rights to Exploit‘Tom Clancy’s Net Force’ Franchise

NovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports...

NovelStem’s Affiliate NewStem Announced New Collaboration to Validate its Software Diagnostic Device

NovelStem Reports Third Quarter Results on Form 10-Q

NovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding...

NovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary

NovelStem Reviews Efforts to Maximize Value from Legacy Entertainment Asset

NovelStem Files Preliminary Financial Statements in Compliance with SEC Rule 15c2-11...

NovelStem Announces NewStem, Ltd. was Selected by Illumina for its Global Illumina Accelerator

NovelStem Increases NewStem Ownership to 33% as NewStem Prepares for First-Half 2021 FDA Filing...

NovelStem Announces New Research Collaborations for Stem-Cell Technology Platform...

NovelStem Provides Shareholder Update

NovelStem Provides Shareholder Update

Hollywood Media Changes Name and Stock Symbol to Novel Stem International Corp. and “NSTM”...

Hollywood Media Completes Transformational Investment in NewStem, Israel-Based Developer...